Clinical Trials on Long Term Care
Total 178296 results
-
Molecular Targeting Technologies, Inc.ClinSmartRecruitingNeuroendocrine TumorsUnited States
-
University of AlbertaRecruiting
-
Imperial College LondonAdvanced Accelerator Applications International SARecruiting
-
Peter MacCallum Cancer Centre, AustraliaRecruitingNeuroendocrine TumorsAustralia
-
First Affiliated Hospital of Fujian Medical UniversityPeking Union Medical College HospitalRecruiting
-
Ascentage Pharma Group Inc.RecruitingNeuroendocrine TumorsChina
-
University of Michigan Rogel Cancer CenterRecruitingNeuroendocrine TumorsUnited States
-
University Hospital, BrestRecruitingNeuroendocrine TumorsFrance
-
Radiomedix, Inc.Orano Med LLCActive, not recruitingNeuroendocrine TumorsUnited States
-
HutchmedNo longer available
-
Société Française d'Endoscopie DigestiveActive, not recruitingNeuroendocrine TumorsFrance, Belgium
-
University Health Network, TorontoCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedNeuroendocrine TumorsUnited States
-
Lowell Anthony, MDTerSera Therapeutics LLCTerminated
-
Radiomedix, Inc.CompletedNeuroendocrine TumorsUnited States
-
Rigshospitalet, DenmarkCompletedNeuroendocrine TumorsDenmark
-
AC Camargo Cancer CenterWithdrawnNeuroendocrine TumorsBrazil
-
Centre Hospitalier Universitaire de BesanconCompleted
-
Institut Paoli-CalmettesCompletedNeuroendocrine Tumors
-
Novartis PharmaceuticalsCompletedDose Escalation Study of Pasireotide (SOM230) in Patients With Advanced Neuroendocrine Tumors (NETs)Neuroendocrine TumorsUnited States
-
Dr. Nayruz KnaanaSheba Medical CenterUnknown
-
Peking Union Medical College HospitalUnknown
-
Curium US LLCApproved for marketing
-
Vastra Gotaland RegionNovartisCompletedNeuroendocrine TumorsSweden
-
European Institute of OncologyCompletedNeuroendocrine TumorsItaly
-
University Hospitals Coventry and Warwickshire...UnknownNeuroendocrine TumorsUnited Kingdom
-
Pamela L. KunzCompletedPhase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine TumorsNeuroendocrine TumorsUnited States
-
Northwell HealthNo longer availableNeuroendocrine Tumors
-
Memorial Sloan Kettering Cancer CenterNo longer availableNeuroendocrine TumorsUnited States
-
University Hospital Schleswig-HolsteinUniversity Hospital FreiburgUnknown
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnRecurrent Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IV Ovarian Epithelial Cancer | Stage IV Ovarian Germ Cell Tumor | Recurrent Ovarian Epithelial Cancer | Recurrent Ovarian Germ Cell Tumor | Stage IIIA Ovarian Germ Cell Tumor | Stage IIIB Ovarian Germ Cell... and other conditionsUnited States
-
Qilu Hospital of Shandong UniversityNot yet recruitingNeuroendocrine TumorsChina
-
University Hospital, AntwerpUniversiteit AntwerpenRecruiting
-
University of AlbertaRecruitingNeuroendocrine TumorsCanada
-
Asan Medical CenterSamsung Medical Center; Seoul St. Mary's Hospital; Seoul National University... and other collaboratorsRecruitingNeuroendocrine TumorsKorea, Republic of
-
Peking Union Medical College HospitalRecruitingNeuroendocrine TumorsChina
-
AHS Cancer Control AlbertaRecruiting
-
University Hospital, Basel, SwitzerlandActive, not recruitingNeuroendocrine TumorsSwitzerland
-
Clarity Pharmaceuticals LtdActive, not recruitingNeuroendocrine TumorsAustralia
-
University Medical Center GroningenCompleted
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Lund University HospitalActive, not recruitingNeuroendocrine TumorsSweden
-
IpsenTerminated
-
Providence Health & ServicesExelixis; Advanced Accelerator Applications SAActive, not recruitingNeuroendocrine TumorsUnited States
-
Medical University InnsbruckNovartisCompletedNeuroendocrine TumorsAustria
-
Latin American Cooperative Oncology GroupFinanciadora de Estudos e Projetos; Instituto do Cérebro do Rio Grande do Sul...CompletedNeuroendocrine TumorsBrazil
-
IRCCS San RaffaeleCompletedNeuroendocrine TumorsItaly
-
Hospices Civils de LyonCompleted